Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TRIPLE TRADES -- Ignore unavailable to you. Want to Upgrade?

To: yard_man who wrote (2501)	6/27/2022 5:18:12 PM
From: Tweets Boar Hog	1 Recommendation Recommended By yard_man Read Replies (2) \| Respond to of 4446

I dumped all my Cohu for Mvis. Both have great looking weekly charts, weekly RSI on each about to go above 50 and I think it will hold on each. But target as high or higher on Mvis, price is 1/5 Cohu. Easy math. I think we are due a long wave, could run into next year imo. Midtine on Mvis between ~ 130 and 200 about end of year. Midtine is also about 3 levels of support above last high. Tweets PS. Just chitting I do believe in diversification. Have full loads of each, but assuming we get going I may move some over to Mvis. From where ever. Still have quite a bit of cash to employ. Have time to read and research more. The EV boom is for real, latter half of 2022 and 2023 going to be a years of the EV's moving up, and rapidly expanding production. Coupled to the hip with the EV boom is the autonomous driving boom, it is coming. This is where Mvis comes in, on the radar of WS. One more often mentioned is LAZR as well as AEVA. There are others. Latter two still falling prolly have quite a ways to go yet. We see. Cohu has a steep fork too.

To: yard_man who wrote (2501)	6/27/2022 5:31:37 PM
From: Tweets Boar Hog	Read Replies (1) \| Respond to of 4446

Biotech looks interesting, I have a first load of LABU. Was a bit early another couple days up will take care of that. I am following Novavax. Novavax is just in process of getting approval for a new Covid vaccine. They (Covid vaccines) are here to stay. Like flu shots. None of that mNRA chit. Vaccine is more traditional type. Refrigeration storage suffices. Possibly much less probability of myocarditus/pericarditus, still to be determined. Data imo looked good. Just following. Lot of potential in this one. Imo. Current opinions seem to vary in that this is a major development, or too little too late to the party. Novavax was one of the recipients of federal funding. i.e. the WARP Speed project. Seems to me it could be a pretty big deal, specially for a small co like Novavax. Especially since it is global, and refrigeration storage suffices. Tweets One might suspect that gap will get filled, bottom of gap ~ 25 bucks.